MARÍA ISABEL
TEJADA MÍNGUEZ
Investigadora hasta 2019
Charité
Berlín, AlemaniaPublicaciones en colaboración con investigadores/as de Charité (6)
2021
-
The phenotypic and genetic spectrum of patients with heterozygous mutations in cyclin M2 (CNNM2)
Human Mutation, Vol. 42, Núm. 4, pp. 473-486
2015
-
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
JAMA - Journal of the American Medical Association, Vol. 313, Núm. 13, pp. 1347-1361
-
Infectious and Immunologic Phenotype of MECP2 Duplication Syndrome
Journal of Clinical Immunology, Vol. 35, Núm. 2, pp. 168-181
2012
-
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Human Mutation, Vol. 33, Núm. 4, pp. 690-702
2011
-
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers
Journal of the National Cancer Institute, Vol. 103, Núm. 2, pp. 105-116
2010
-
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction
Cancer Research, Vol. 70, Núm. 23, pp. 9742-9754